These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1468211)

  • 1. Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model.
    Stevens RK; Holland GN; Paschal JF; Phinney RB; Berlin OG; Bruckner DA
    Cornea; 1992 Nov; 11(6):500-4. PubMed ID: 1468211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
    Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
    Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.
    Shih MH; Huang FC
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):223-9. PubMed ID: 20811055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
    Helm CJ; Holland GN; Lin R; Berlin OG; Bruckner DA
    Am J Ophthalmol; 1993 Dec; 116(6):700-7. PubMed ID: 8250072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H; Ozbilge H; Oguz E; Gurkan T
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium fortuitum keratitis. Clinicopathologic correlates and corticosteroid effects in an animal model.
    Paschal JF; Holland GN; Sison RF; Berlin OG; Bruckner DA; Dugel PU; Foos RY
    Cornea; 1992 Nov; 11(6):493-9. PubMed ID: 1468210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
    Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
    Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis.
    Pacheco PA; Tam PM
    J Cataract Refract Surg; 2010 May; 36(5):843-6. PubMed ID: 20457379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
    Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination drug testing of Mycobacterium chelonae.
    Matoba AY; Lee BL; Robinson NM; Penland R; Osato MS
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2786-9. PubMed ID: 8344799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model.
    Lin R; Holland GN; Helm CJ; Elias SJ; Berlin OG; Bruckner DA
    Am J Ophthalmol; 1994 May; 117(5):657-62. PubMed ID: 8172274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of topical antibiotics for treating Mycobacterium chelonae keratitis in a rabbit model.
    Hu FR; Wang IJ
    Curr Eye Res; 1998 May; 17(5):478-82. PubMed ID: 9617541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
    Hu FR; Luh KT
    Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
    Karicherla P; Hobden JA
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit Streptococcus pneumoniae keratitis model and topical therapy.
    Guzek JP; Cline DJ; Row PK; Wessels IF; Beeve S; Ispirescu S; Aprecio RM; Kettering JD; Gano DL; Nelson GM
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2012-7. PubMed ID: 9761279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
    Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
    Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.